Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 31;12(2):341.
doi: 10.3390/antiox12020341.

Effect of Resveratrol on Pregnancy, Prenatal Complications and Pregnancy-Associated Structure Alterations

Affiliations
Review

Effect of Resveratrol on Pregnancy, Prenatal Complications and Pregnancy-Associated Structure Alterations

Iman Ramli et al. Antioxidants (Basel). .

Abstract

Adverse pregnancy outcomes are considered significant health risks for pregnant women and their offspring during pregnancy and throughout their lifespan. These outcomes lead to a perturbated in-utero environment that impacts critical phases of the fetus's life and correlates to an increased risk of chronic pathological conditions, such as diabetes, obesity, and cardiovascular diseases, in both the mother's and adult offspring's life. The dietary intake of naturally occurring antioxidants promotes health benefits and disease prevention. In this regard, maternal dietary intake of polyphenolic antioxidants is linked to a reduced risk of maternal obesity and cardio-metabolic disorders, positively affecting both the fetus and offspring. In this work, we will gather and critically appraise the current literature highlighting the effect/s of the naturally occurring polyphenol antioxidant resveratrol on oxidative stress, inflammation, and other molecular and physiological phenomena associated with pregnancy and pregnancy conditions, such as gestational diabetes, preeclampsia, and preterm labor. The resveratrol impact on prenatal complications and pregnancy-associated structures, such as the fetus and placenta, will also be discussed. Finally, we will draw conclusions from the current knowledge and provide future perspectives on potentially exploiting resveratrol as a therapeutic tool in pregnancy-associated conditions.

Keywords: fetus; gestational diabetes; placenta; pre-eclampsia; pregnancy; prenatal; preterm; resveratrol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Potential molecular mechanisms underpinning the effects of resveratrol intake in mothers and their offspring in different models.
Figure 2
Figure 2
Maternal resveratrol supplementation decreases the risk of adverse pregnancy outcomes by ameliorating the in-utero conditions. Schematic representation of the resveratrol-impacted crosstalk between abnormal in-utero conditions and adverse pregnancy risk.

Similar articles

Cited by

References

    1. Jowell A.R., Sarma A.A., Gulati M., Michos E.D., Vaught A.J., Natarajan P., Powe C.E., Honigberg M.C. Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes: A Review. JAMA Cardiol. 2022;7:346–355. doi: 10.1001/jamacardio.2021.4391. - DOI - PMC - PubMed
    1. Parikh N.I., Gonzalez J.M., Anderson C.A.M., Judd S.E., Rexrode K.M., Hlatky M.A., Gunderson E.P., Stuart J.J., Vaidya D., On behalf of the American Heart Association Council on Epidemiology and Prevention et al. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation. 2021;143:e902–e916. doi: 10.1161/CIR.0000000000000961. - DOI - PubMed
    1. Darby J.R.T., Dollah M.H.B.M., Regnault T.R.H., Williams M.T., Morrison J.L. Systematic review: Impact of resveratrol exposure during pregnancy on maternal and fetal outcomes in animal models of human pregnancy complications-Are we ready for the clinic? Pharmacol. Res. 2019;144:264–278. doi: 10.1016/j.phrs.2019.04.020. - DOI - PubMed
    1. Phu H.T., Thuan D.T., Nguyen T.H., Posadino A.M., Eid A.H., Pintus G. Herbal medicine for slowing aging and aging-associated conditions: Efficacy, mechanisms and safety. Curr. Vasc. Pharmacol. 2020;18:369–393. doi: 10.2174/1570161117666190715121939. - DOI - PubMed
    1. Hossain R., Quispe C., Khan R.A., Saikat A.S.M., Ray P., Ongalbek D., Yeskaliyeva B., Jain D., Smeriglio A., Trombetta D. Propolis: An update on its chemistry and pharmacological applications. Chin. Med. 2022;17:100. - PMC - PubMed

LinkOut - more resources